RxDoctor Payments Data

Ridhi Kratzmeyer, DPM

Foot Surgery · Elgin, ILNPI 1891177978

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations.

$2,096in general payments, 2019–2025

Across 67 payments — averaging $31.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$446
  • Stryker$372
  • Smith+Nephew$281
  • Aroa Biosurgery Incorporated$190
  • Kerecis Limited$159
  • Integra Lifesciences Corporation$147
  • plus $501 from 16 others

What the payments were for

  • Food & beverage$2,096100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,096 in reported general payments places this provider in the 70th percentile of 51 foot surgery providers in Illinois.

See all foot surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$156,784
Medicare patients
256
Services billed
1,762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gentamicin Sulfate17$169
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$94
Methylprednisolone12$63
Meloxicam13$10

Paid to pharmacies, not to this prescriber.

Other foot surgery in Elgin

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →